Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

29.4%

144 terminated/withdrawn out of 490 trials

Success Rate

64.4%

-22.1% vs industry average

Late-Stage Pipeline

3%

13 trials in Phase 3/4

Results Transparency

36%

95 of 261 completed trials have results

Key Signals

48 recruiting95 with results69 terminated75 withdrawn

Enrollment Performance

Analytics

N/A
180(41.9%)
Phase 2
133(30.9%)
Phase 1
78(18.1%)
Early Phase 1
26(6.0%)
Phase 3
12(2.8%)
Phase 4
1(0.2%)
430Total
N/A(180)
Phase 2(133)
Phase 1(78)
Early Phase 1(26)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (490)

Showing 20 of 490 trials
NCT06435871Not ApplicableActive Not Recruiting

Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors

Role: lead

NCT06336538Not ApplicableActive Not Recruiting

Abbreviated MBCT for Depression in Older Black or African American Breast Cancer Survivors

Role: lead

NCT04620603Phase 1Active Not Recruiting

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

Role: lead

NCT06101069Not ApplicableRecruiting

Development of MRF for Characterization of Brain Tumors After Radiotherapy

Role: lead

NCT07060261Not ApplicableRecruiting

Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma

Role: lead

NCT07040501Not ApplicableNot Yet Recruiting

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

Role: lead

NCT07419581Not ApplicableNot Yet Recruiting

A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment

Role: lead

NCT06926530Not Yet Recruiting

Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations

Role: lead

NCT07117032Phase 1Not Yet Recruiting

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain

Role: lead

NCT04348123Not ApplicableCompleted

Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography

Role: lead

NCT06446115Not ApplicableCompleted

Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer

Role: lead

NCT07524634Phase 2Not Yet Recruiting

Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

Role: lead

NCT07541365Not ApplicableNot Yet Recruiting

Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials

Role: lead

NCT07541066Not ApplicableWithdrawn

Robotic Telesurgery in Urology

Role: lead

NCT07129226Not ApplicableRecruiting

Musculoskeletal Cancers Remote Monitoring and Care

Role: lead

NCT07219472Not ApplicableRecruiting

Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy

Role: lead

NCT07104630Phase 2Recruiting

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Role: lead

NCT06421155Not ApplicableSuspended

Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia

Role: lead

NCT06084780Phase 2Not Yet Recruiting

Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)

Role: lead

NCT04624555Recruiting

The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

Role: lead